Marsh went first.
She stood before the jury with no notes visible — she'd memorized it, or she'd prepared so thoroughly that memory wasn't necessary — and she began with something no one expected her to begin with.
"My client employs 12,000 people," she said. "I want to start there. Not because large companies are above accountability — they're not. But because I want you to understand who you're deciding about today. Scientists. Regulatory specialists. Clinical researchers. People who spent careers developing medications for cardiovascular disease, which kills 600,000 Americans every year. People who believe, with genuine conviction, that they were doing their best work for people who needed it."
She moved along the jury box slowly.
"Dr. Rowe is a scientist. She is capable, intelligent, and genuinely convinced of her interpretation of this data. We are not asking you to disbelieve her honesty. We are asking you to consider that honest scientists can look at the same data and reach different conclusions. That is not fraud. That is the nature of complex medical research."
She named three pharmaceutical drugs — I recognized two of them from my research on pharmaceutical dispute history. Real cases where adverse event profiles had been contested, revised, and ultimately settled through regulatory process rather than litigation. In each case, the company that had been wrong had not been criminally fraudulent. They'd been operating within the limits of scientific knowledge that was genuinely evolving.
"The classification threshold change that plaintiff has characterized as 'engineering fraud' is a modification that falls within the range of scientific judgment. The vendor's work was performed during the same window. The documentation supports an innocent explanation."
She didn't rush.
"Dr. Chen showed you impressive charts. But Dr. Chen's conclusion — that the backup file is definitive proof of deliberate manipulation rather than one possible explanation among several — is his interpretation. Meridian's experts offered a different interpretation. The question is not which expert is smarter. The question is whether, with all the interpretations available, you can say beyond a reasonable doubt that this was fraud and not scientific judgment."
She sat down.
It was her best work. It was almost enough.
I stood.
I had been preparing this closing for three weeks, and then had thrown away the last version two days ago because I'd understood something about what Marsh was going to argue and had rewritten it.
"Counsel is right that scientific disagreement is not fraud," I said. "She's right that pharmaceutical research is complex. She's right that Meridian employs 12,000 people who are working, genuinely, on cardiovascular disease."
I paused.
"I want to agree with everything she said. Because it's all true. And I want to add one more thing."
I walked to the display screen.
"On the left: Section 4 of Meridian's vendor agreement with their software provider. This is what the vendor contracted to do during the March 14th maintenance window." I clicked to the highlighted language. "Processing speed optimization. Server load reduction. Report interface improvements." I paused. "Classification thresholds are not in Section 4. They're not in Section 1, 2, 3, 5, or 6. They're not in the statement of work, the change request, the acceptance documentation, or the vendor's own work log."
I clicked to Exhibit 47 on the right side of the screen.
"On the right: the version history modification from March 14th, 2011. The parameter changed: adverse event classification threshold. Severity level 2 cardiac events reclassified as 'unrelated to study drug.'"
Both documents side by side. The jury could read them simultaneously.
"One of these modifications was in the vendor contract. One of them was not." I stepped away from the screen. "When counsel says the vendor contract provides an innocent explanation for the March 14th modification — she is correct that the vendor was in the system on March 14th. She is not correct that the modification in Exhibit 47 was the vendor's work. Those are different claims."
I faced the jury directly.
"Forty-seven people. Who were told this drug was safe. Who are in this room today. The evidence shows that on March 7th, 2011, the CEO of Meridian Pharmaceuticals received an email describing a concern about the exact category of cardiac events that was subsequently reclassified. Seven days later, that category was reclassified. Six days after that, the FDA application was submitted with the reclassified data."
The courtroom was quiet.
"Counsel described Meridian's employees as doing their best work for people who needed it. I believe most of them were. The question is whether the people who authorized that parameter change on March 14th were doing their best work for those patients, or whether they were doing something else." I looked at the jury. "The evidence tells you what they were doing. I'm asking you to read it."
I sat down.
The room held its particular quality for a moment — the held breath of a space where something important has just been said and everyone is still deciding what it means.
The jury was released to deliberate at 3:47 PM.
The four of us — me, Marcus, Sarah, Dr. Rowe — found seats in the courthouse cafeteria because the courthouse hallways had been the territory of the past six weeks and the cafeteria felt marginally less like waiting in the same spot where all the tension lived.
The vending machine hummed. Someone's coffee was burning on a warming element somewhere. A marshal walked through with a file folder and didn't look at us.
Dr. Rowe had her hands on the table, still.
Marcus was reviewing something on his phone. After a moment, he put it away.
Sarah had a legal pad and wasn't writing anything on it.
I ate a granola bar from the vending machine that had been in the machine since at least November and tasted like compressed apology.
"Whatever happens," Dr. Rowe said finally, "what you built here was worth building."
"The verdict is what makes it matter," I said.
She looked at me.
"No," she said. "The truth on record is what makes it matter. The verdict is what makes it actionable." She paused. "The transcript of this trial exists regardless of what twelve people decide. The algorithm modification is in the public record. The deposition testimony, the backup file analysis, the executive meeting timeline — all of it exists now in a way that it didn't before we walked into that courtroom six weeks ago." She looked at her hands. "Every pharmaceutical company that reads this trial record knows we can find what they buried. That changes the calculus regardless of the verdict."
I thought about Donna after Hessington, sitting in the car: the value of the case isn't just the outcome, it's the evidence that now exists in the public record regardless of outcome.
Different person. Same truth.
I didn't offer her reassurance about the verdict. I didn't have a Win Rate Calculator output that meant anything at this point, and performative confidence in a cafeteria after six weeks of trial would have been the wrong kind of comfort.
"I believe that," I said.
She nodded.
Donna met me on the courthouse steps.
She was eight months pregnant and managing a consulting firm and had still arrived at 4:15 PM because she knew closing arguments were today and she hadn't missed a single day of the trial she could attend. She looked exactly like herself.
She didn't say anything about the Win Rate Calculator. She took my hand.
We walked six blocks. March air, cold but specific — the kind that was carrying a hint of something warmer underneath, the city beginning to remember that spring was possible.
"How do you feel?" she said.
"Like I did everything I could."
She nodded.
"Then we wait," she said.
A LOT More chapters reign FREE upon unwrittenrealm.com.
• Normal | $8 — 15 chapters ahead
• Advanced | $11 — 20 chapters ahead
• Overlord | $19 — 25 chapters ahead, plus request a refinement (plot, character, system) on any of my novels
patreon.com/TheFinex5
▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰
― DECREE ―
More chapters reign FREE upon unwrittenrealm.com.
The throne acknowledges.
▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰▰